These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22587794)

  • 41. Salvianolic Acid B Ameliorates Lipopolysaccharide-Induced Albumin Leakage from Rat Mesenteric Venules through Src-Regulated Transcelluar Pathway and Paracellular Pathway.
    Pan CS; Liu YH; Liu YY; Zhang Y; He K; Yang XY; Hu BH; Chang X; Wang MX; Wei XH; Fan JY; Wu XM; Han JY
    PLoS One; 2015; 10(5):e0126640. PubMed ID: 25992563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive dysfunctions induced by a cholinergic blockade and Aβ 25-35 peptide are attenuated by salvianolic acid B.
    Kim DH; Park SJ; Kim JM; Jeon SJ; Kim DH; Cho YW; Son KH; Lee HJ; Moon JH; Cheong JH; Ko KH; Ryu JH
    Neuropharmacology; 2011 Dec; 61(8):1432-40. PubMed ID: 21903108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of food on the oral bioavailability of deramciclane from film-coated tablet in healthy male volunteers.
    Drabant S; Nemes KB; Horváth V; Tolokán A; Grézal G; Anttila M; Gachályi B; Kanerva H; Al-Behaisi S; Horvai G; Klebovich I
    Eur J Pharm Biopharm; 2004 Nov; 58(3):689-95. PubMed ID: 15451546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-alpha treated human umbilical vein endothelial cells.
    Zhou Z; Liu Y; Miao AD; Wang SQ
    J Cell Biochem; 2005 Sep; 96(1):109-16. PubMed ID: 16052513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1.
    Liu M; Ye J; Gao S; Fang W; Li H; Geng B; Zou J; Chen X; Chen S; Zhang L; Yue Z; Ma Y; Gao H; Li Z; Liu P
    Biochem Biophys Res Commun; 2014 Feb; 444(3):346-53. PubMed ID: 24462865
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salvianolic acid B inhibits fibril formation and neurotoxicity of amyloid beta-protein in vitro.
    Tang MK; Zhang JT
    Acta Pharmacol Sin; 2001 Apr; 22(4):380-4. PubMed ID: 11742594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Study on tissue distribution of borneol in mice by intravenous and intranasal administrations].
    Zhao JY; Du SY; Lu Y; Wu HC; Li HY
    Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(7):1071-4. PubMed ID: 23847960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Salvianolic acid B alleviate the disruption of blood-brain barrier in rats after cerebral ischemia-reperfusion by inhibiting MAPK pathway].
    Li Q; Han LP; Li ZH; Zhang JT; Tang MK
    Yao Xue Xue Bao; 2010 Dec; 45(12):1485-90. PubMed ID: 21351487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of salvianolic acid B and tetrahydropalmatine on the L-type calcium channel of rat ventricular myocytes].
    Meng HX; Wang B; Liu JX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Nov; 31(11):1514-7. PubMed ID: 22303716
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of lithospermic acid B isolated from Salvia miltiorrhiza in rats.
    Kim HH; Kim J; Ji HY; Kim YC; Sohn DH; Lee BM; Lee HS
    J Toxicol Environ Health A; 2005 Dec; 68(23-24):2239-47. PubMed ID: 16326437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Borneol administration protects primary rat hepatocytes against exogenous oxidative DNA damage.
    Horváthová E; Kozics K; Srančíková A; Hunáková L; Gálová E; Ševčovičová A; Slameňová D
    Mutagenesis; 2012 Sep; 27(5):581-8. PubMed ID: 22544524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The identification and pharmacokinetic studies of metabolites of salvianolic acid B after intravenous administration in rats.
    Qi Q; Hao K; Li FY; Cao LJ; Wang GJ; Hao HP
    Chin J Nat Med; 2013 Sep; 11(5):560-5. PubMed ID: 24359784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antidepressant-like effects of salvianolic acid B in the mouse forced swim and tail suspension tests.
    Feng Y; You Z; Yan S; He G; Chen Y; Gou X; Peng C
    Life Sci; 2012 Jun; 90(25-26):1010-4. PubMed ID: 22683428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative pharmacokinetics of senkyunolide I in a rat model of migraine versus normal controls.
    Wang YH; Hong YL; Feng Y; Xu DS; Liang S; Lin X; Shen L
    Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):91-7. PubMed ID: 22322984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of antioxidant activities between salvianolic acid B and Ginkgo biloba extract (EGb 761).
    Liu CS; Cheng Y; Hu JF; Zhang W; Chen NH; Zhang JT
    Acta Pharmacol Sin; 2006 Sep; 27(9):1137-45. PubMed ID: 16923333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioavailability of salvianolic acid B in conscious and freely moving rats.
    Wu YT; Chen YF; Hsieh YJ; Jaw I; Shiao MS; Tsai TH
    Int J Pharm; 2006 Dec; 326(1-2):25-31. PubMed ID: 16905282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salvianolic acid B protects human endothelial progenitor cells against oxidative stress-mediated dysfunction by modulating Akt/mTOR/4EBP1, p38 MAPK/ATF2, and ERK1/2 signaling pathways.
    Tang Y; Jacobi A; Vater C; Zou X; Stiehler M
    Biochem Pharmacol; 2014 Jul; 90(1):34-49. PubMed ID: 24780446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salvianolic acid B protects against acetaminophen hepatotoxicity by inducing Nrf2 and phase II detoxification gene expression via activation of the PI3K and PKC signaling pathways.
    Lin M; Zhai X; Wang G; Tian X; Gao D; Shi L; Wu H; Fan Q; Peng J; Liu K; Yao J
    J Pharmacol Sci; 2015 Feb; 127(2):203-10. PubMed ID: 25727958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioavailability of the Phenolic Antioxidant 4-Methyl-2,6-Diisobornylphenol After Oral Administration.
    Chernysheva GA; Smolyakova VI; Yanovskaya EA; Kutchin AV; Chukicheva IY; Udut VV; Plotnikov MB
    Bull Exp Biol Med; 2016 Aug; 161(4):505-7. PubMed ID: 27590757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.